Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
CRON | US
0.08
3.08%
Healthcare
Biotechnology
30/06/2024
24/04/2026
2.68
2.61
2.69
2.54
Cronos Group Inc. operates as a cannabinoid company. It manufactures markets and distributes hemp-derived supplements and cosmetic products through e-commerce retail and hospitality partner channels under the Lord Jones brand in the United States. The company is also involved in the cultivation manufacture and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. It sells cannabis and cannabis products including dried cannabis pre-rolls edibles concentrates and cannabis extracts through wholesale and direct-to-client channels under its wellness platform PEACE NATURALS; and operates under adult-use brands Spinach. Cronos Group Inc. was founded in 2012 and is based in Toronto Canada.
View LessLow Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Strong Revenue Growth (> 10%)
High Short-term Volatility
Smallcap (300M - 2B USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
52.7%1 month
43.0%3 months
37.4%6 months
43.5%-
-
0.79
0.00
0.00
-1.42
0.02
-
-61.51M
1.03B
1.03B
-
-54.08
14.40
46.00
-5.29
5.63
2.49
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
0.74
Range1M
0.85
Range3M
0.88
Rel. volume
0.97
Price X volume
4.68M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Pharming Group N.V. | PHAR | Biotechnology | 16.68 | 1.13B | 0.24% | n/a | 63.43% |
| Oculis Holding AG Ordinary shares | OCS | Biotechnology | 26.44 | 1.10B | -1.23% | n/a | 1.19% |
| Wave Life Sciences Ltd | WVE | Biotechnology | 7.18 | 1.09B | -1.78% | n/a | 656.70% |
| MoonLake Immunotherapeutics | MLTX | Biotechnology | 17.18 | 1.08B | 1.48% | n/a | 0.64% |
| Cue Biopharma Inc | CUE | Biotechnology | 17.695 | 1.07B | 6.43% | n/a | 52.09% |
| GH Research PLC Ordinary Shares | GHRS | Biotechnology | 20.25 | 1.05B | 7.66% | n/a | 0.38% |
| VIRIDIAN THERAPEUTICS ORS INC | VRDN | Biotechnology | 13.73 | 1.05B | -3.51% | n/a | 3.96% |
| Trevi Therapeutics Inc | TRVI | Biotechnology | 14.41 | 1.05B | 1.55% | n/a | 1.80% |
| Iovance Biotherapeutics Inc | IOVA | Biotechnology | 3.44 | 1.04B | -1.15% | n/a | 10.63% |
| Recursion Pharmaceuticals Inc. Class A Common Stock | RXRX | Biotechnology | 3.51 | 1.02B | 0.29% | n/a | 15.38% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Winnebago Industries Inc | WGO | Recreational Vehicles | 32.87 | 951.75M | 0.70% | 22.53 | 56.33% |
| Janus International Group Inc. | JBI | Building Products & Equipment | 5.44 | 790.55M | 1.30% | 11.62 | 116.21% |
| Fox Factory Holding Corp | FOXF | Recreational Vehicles | 17.7 | 737.79M | 2.31% | 42.05 | 64.69% |
| Latham Group Inc. | SWIM | Building Products & Equipment | 6.01 | 694.62M | -0.17% | 65.18 | 77.00% |
| Ennis Inc | EBF | Building Products & Equipment | 20.33 | 528.66M | -1.26% | 13.28 | 2.28% |
| Malibu Boats Inc | MBUU | Recreational Vehicles | 26.1 | 521.76M | -0.91% | n/a | 1.50% |
| MCBC Holdings Inc | MCFT | Recreational Vehicles | 23.53 | 390.77M | -0.88% | 34.27 | 26.82% |
| Camping World Holdings Inc | CWH | Recreational Vehicles | 7.48 | 337.57M | 8.41% | n/a | 3644.76% |
| ACCO Brands Corporation | ACCO | Building Products & Equipment | 3.31 | 317.09M | 1.85% | n/a | 174.23% |
| Marine Products Corporation | MPX | Recreational Vehicles | 7.99 | 277.39M | -0.99% | 13.23 | 0.00% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -1.42 | - | Cheaper |
| Ent. to Revenue | 0.02 | - | Cheaper |
| PE Ratio | - | 41.03 | - |
| Price to Book | 0.79 | 15.55 | Cheaper |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 37.45 | - | Lower Risk |
| Debt to Equity | 0.00 | -1.23 | Expensive |
| Debt to Assets | 0.00 | 0.25 | Cheaper |
| Market Cap | 1.03B | - | Emerging |